primary PCI
Showing 9976 - 10000 of >10,000
Tobacco Use Cessation Trial (iCanQuit, iCanQuit+Motiv8, Florida quit line)
Not yet recruiting
- Tobacco Use Cessation
- iCanQuit
- +2 more
- (no location specified)
Aug 17, 2022
CKD Anemia in Stable Dialysis Patients Trial in Puerto Rico, United States (Epoetin Alfa, Roxadustat)
Completed
- CKD Anemia in Stable Dialysis Patients
- Epoetin Alfa
- Roxadustat
-
Phoenix, Arizona
- +75 more
Sep 30, 2021
Hypertension Trial (Pharmaceutical care via telepharmacy and usual care, Pharmaceutical care in-person and usual care)
Not yet recruiting
- Hypertension
- Pharmaceutical care via telepharmacy and usual care
- Pharmaceutical care in-person and usual care
- (no location specified)
Nov 1, 2023
COVID-19 Trial in Amsterdam ([18F]DPA-714 positron emission tomography (PET) scan)
Enrolling by invitation
- COVID-19
- [18F]DPA-714 positron emission tomography (PET) scan
-
Amsterdam, NetherlandsVU University Medical Center
May 11, 2022
Overweight, Family Relations, Adolescent Behavior Trial in Miami (Familias Unidas)
Completed
- Overweight
- +4 more
- Familias Unidas
-
Miami, FloridaUniversity of Miami
May 7, 2022
Ultrasound and Nerve Stimulator Techniques for Nerve
Withdrawn
- Orthopedic
-
New Orleans, LouisianaOchsner Clinic Foundation
Apr 19, 2022
Wound Infection Trial (MolecuLight DX Imaging Device)
Not yet recruiting
- Wound Infection
- MolecuLight DX Imaging Device
- (no location specified)
Jan 18, 2022
Painful Breastfeeding Trial in Bordeaux (Breastfeeding usual known aids and osteopathic treatment, Breastfeeding usual known
Recruiting
- Painful Breastfeeding
- Breastfeeding usual known aids and osteopathic treatment
- Breastfeeding usual known aids
-
Bordeaux, FranceCHU de Bordeaux
Apr 11, 2022
Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery Trial in Australia, Singapore (TH BSO with SNB Note: If participants
Recruiting
- Endometrial Cancer Stage I
- +2 more
- TH BSO with SNB Note: If participants (≤45 years of age) wish to retain their ovaries a BSO may be omitted.
- TH BSO without retroperitoneal node dissection Note: If participants (≤45 years of age) wish to retain their ovaries a BSO may be omitted.
-
Camperdown, New South Wales, Australia
- +12 more
Sep 7, 2022
Type 1 Diabetes Trial in Puerto Rico, United States (HOE901-U300 (Insulin Glargine 300 U/ml), Lantus (Insulin Glargine 100
Completed
- Type 1 Diabetes Mellitus
- HOE901-U300 (Insulin Glargine 300 U/ml)
- +2 more
-
Little Rock, Arkansas
- +99 more
Mar 21, 2022
Laceration, Skin Wound, Wound Heal Trial in Orange (microMend®, Closure with Sutures)
Recruiting
- Laceration
- +2 more
- microMend®
- Closure with Sutures
-
Orange, CaliforniaCHOC Children's
Mar 11, 2022
Asthma Trial in Atlanta (Albuterol Sulfate, Interferon gamma-primed mesenchymal stromal cells (MSCs), Prednisone)
Recruiting
- Asthma
- Albuterol Sulfate
- +2 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jul 21, 2022
Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)
Active, not recruiting
- Coronary Artery Diseasse
- fixed high potent statin therapy
- targeted LDL-C goal statin
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022
Breast Cancer Trial in Avignon, Besançon, Lyon (Connected device, Therapeutic education)
Active, not recruiting
- Breast Cancer
- Connected device
- Therapeutic education
-
Avignon, France
- +2 more
Jul 22, 2022
Dysmenorrhea Primary Trial in Old Westbury (Osteopathic manipulative medicine)
Recruiting
- Dysmenorrhea Primary
- Osteopathic manipulative medicine
-
Old Westbury, New YorkRiland Academic Health Care Center
Feb 16, 2022
Heel Spur Trial in Brno (Standard fractioned dose, Experimental single dose)
Recruiting
- Heel Spur
- Standard fractioned dose
- Experimental single dose
-
Brno, CzechiaMasaryk Memorial Cancer Institute
Oct 30, 2023
Dermatology Trial in Bologna (Neoviderm Skin Emulsion medical device, Connettivina 0.2% Cream)
Not yet recruiting
- Dermatology
- Neoviderm Skin Emulsion medical device
- Connettivina 0.2% Cream
-
Bologna, ItalyUO Dermatologia - Piraccini IRCCS Azienda Ospedaliero-Universita
Apr 6, 2023
isProspective, Multi-center, Real World, Observational Study,
Recruiting
- Peripheral Arterial Disease
-
Shanghai, ChinaZhongshan Hospital, Fudan University
May 23, 2022
Fibrinogen, Spine Deformity, Coagulopathy, Consumption Trial (Fibrinogen Concentrate Human)
Not yet recruiting
- Fibrinogen
- +3 more
- Fibrinogen Concentrate Human
- (no location specified)
May 24, 2022
Complication and Lung Function Impairment Prediction Using
Recruiting
- Non-small Cell Lung Cancer
- Predictive data
- Lung resection
-
Montpellier, FranceChu Montpellier
Dec 30, 2021
Obesity Trial in Cleveland (Go! Foods for You without Weekly MA Support., Go! Foods for You with Weekly MA Support.)
Withdrawn
- Obesity
- Go! Foods for You without Weekly MA Support.
- Go! Foods for You with Weekly MA Support.
-
Cleveland, OhioCleveland Clinic Foundation
May 6, 2022
Obesity, Overweight Trial in New York (Peer Assisted Lifestyle, Enhanced Usual Care)
Completed
- Obesity
- Overweight
- Peer Assisted Lifestyle
- Enhanced Usual Care
-
New York, New YorkManhattan Campus of the VA NY Harbor Healthcare System, New York
Feb 9, 2022
HaemoDYNAMICs in Primary and Secondary Hypertension
Recruiting
- Primary Hypertension
- +3 more
- Nitroglycerin 0.25 mg (single dose, no longer given since January 2017)
- +5 more
-
Tampere, Southern Finland, Finland
- +1 more
Aug 12, 2021
(PRRT) for the Treatment of Neuroendocrine Tumors
Enrolling by invitation
- Neuroendocrine Tumors
- Peptide Receptor Radionuclide Therapy
-
Dallas, TexasMethodist Dallas Medical Center
Oct 27, 2021
Glioblastoma, Glioblastoma, WHO Grade IV Trial in Gainesville (Temozolomide (TMZ), Optune System, Pembrolizumab)
Active, not recruiting
- Glioblastoma
- Glioblastoma, WHO Grade IV
- Temozolomide (TMZ)
- +2 more
-
Gainesville, FloridaUniversity of Florida Health
Aug 22, 2022